Reata Pharmaceuticals Inc - Class A (RETA) Dividend History

Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, Reata is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs, which dually activate the antioxidative transcription factor Nrf2 and inhibit the pro-inflammatory transcription factor NF-κB. The antioxidative and anti-inflammatory compounds bardoxolone methyl and RTA 408 are the lead clinical development compounds in Reata’s portfolio.

Last update 05/28/2022


Dividend Yield Summary

  2017 2018 2019 2020 2021 2022
Dividends - - - - - -
Average Price 26.82 47.03 109.37 150.01 106.00 29.37
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2022 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note